GlassScriptPhysician profile
Yusuf Aref
NPI 1386099786
$1,448.95
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $118 · 2023: $1,162 · 2024: $18.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.00 |
| Travel and Lodging | $225.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $796.54 | 2022-2023 | Intracept |
| Vertos Medical, INC. | $170.35 | 2021-2023 | Mild Device Kit |
| Medtronic, INC. | $115.61 | 2021-2023 | Intellis Adaptivestim |
| Abbvie INC. | $101.12 | 2023 | Botox |
| Nevro Corp. | $82.34 | 2023 | Senza |
| Merit Medical Systems INC | $53.09 | 2023 | Stabilit |
| Curonix LLC | $24.09 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $24.01 | 2021-2022 | |
| Boston Scientific Corporation | $18.82 | 2024 | Intracept |
| Si-Bone, INC. | $17.92 | 2023 | |
| Sonex Health, INC. | $16.69 | 2021 | |
| Almatica Pharma LLC | $16.26 | 2023 | Gralise |
| Biodelivery Sciences International, INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yusuf Aref listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.